Form 8-K - Current report:
SEC Accession No. 0001683168-24-006436
Filing Date
2024-09-17
Accepted
2024-09-16 19:01:51
Documents
14
Period of Report
2024-09-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT intlstemcell_8k.htm   iXBRL 8-K 29280
2 FORM OF NOTE ISSUED ON SEPTEMBER 15, 2024 intlstemcell_ex1001.htm EX-10.1 16451
  Complete submission text file 0001683168-24-006436.txt   216673

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE isco-20240915.xsd EX-101.SCH 3054
4 XBRL LABEL FILE isco-20240915_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE isco-20240915_pre.xml EX-101.PRE 22385
16 EXTRACTED XBRL INSTANCE DOCUMENT intlstemcell_8k_htm.xml XML 3246
Mailing Address 9745 BUSINESSPARK AVENUE SAN DIEGO CA 92131
Business Address 9745 BUSINESSPARK AVENUE SAN DIEGO CA 92131 760-940-6383
International Stem Cell CORP (Filer) CIK: 0001355790 (see all company filings)

EIN.: 204494098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51891 | Film No.: 241302190
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)